Sumant Inamdar
Concepts (299)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholangiopancreatography, Endoscopic Retrograde | 18 | 2024 | 90 | 5.170 |
Why?
| Pancreatitis | 11 | 2023 | 57 | 4.690 |
Why?
| Drainage | 9 | 2024 | 79 | 1.850 |
Why?
| Cholangitis | 3 | 2019 | 12 | 1.780 |
Why?
| Barrett Esophagus | 10 | 2024 | 29 | 1.590 |
Why?
| Pancreatitis, Chronic | 3 | 2023 | 10 | 1.510 |
Why?
| Biliary Tract | 3 | 2023 | 12 | 1.380 |
Why?
| Cholestasis | 2 | 2022 | 40 | 1.290 |
Why?
| Endosonography | 12 | 2024 | 94 | 1.220 |
Why?
| Endoscopy, Gastrointestinal | 12 | 2024 | 76 | 1.150 |
Why?
| Bile Ducts | 2 | 2017 | 47 | 1.050 |
Why?
| Humans | 83 | 2025 | 49898 | 1.020 |
Why?
| Stents | 10 | 2024 | 346 | 0.970 |
Why?
| Gastroenterology | 4 | 2024 | 27 | 0.960 |
Why?
| Postoperative Complications | 7 | 2025 | 1018 | 0.940 |
Why?
| Esophageal Neoplasms | 6 | 2024 | 103 | 0.930 |
Why?
| Liver | 2 | 2021 | 1106 | 0.810 |
Why?
| Child Mortality | 1 | 2021 | 11 | 0.770 |
Why?
| Hospitalization | 10 | 2023 | 663 | 0.750 |
Why?
| Infant Mortality | 1 | 2021 | 57 | 0.740 |
Why?
| Gastrointestinal Hemorrhage | 5 | 2024 | 79 | 0.740 |
Why?
| Cholestasis, Intrahepatic | 1 | 2021 | 6 | 0.740 |
Why?
| Sphincterotomy, Endoscopic | 3 | 2022 | 15 | 0.740 |
Why?
| Peritonitis | 2 | 2022 | 27 | 0.730 |
Why?
| Colonoscopy | 5 | 2025 | 96 | 0.730 |
Why?
| Gastric Bypass | 2 | 2024 | 19 | 0.720 |
Why?
| Pancreas | 5 | 2023 | 71 | 0.710 |
Why?
| Duodenal Neoplasms | 1 | 2020 | 15 | 0.710 |
Why?
| Endoscopy, Digestive System | 6 | 2021 | 51 | 0.700 |
Why?
| Cholecystitis | 1 | 2019 | 12 | 0.680 |
Why?
| Intestinal Perforation | 1 | 2019 | 23 | 0.680 |
Why?
| Fatty Liver | 1 | 2021 | 126 | 0.670 |
Why?
| Postoperative Hemorrhage | 1 | 2019 | 52 | 0.660 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 122 | 0.650 |
Why?
| Pancreatic Neoplasms | 4 | 2023 | 209 | 0.640 |
Why?
| Risk Factors | 12 | 2023 | 3604 | 0.620 |
Why?
| Retrospective Studies | 20 | 2024 | 6123 | 0.590 |
Why?
| Cholangiopancreatography, Magnetic Resonance | 1 | 2017 | 9 | 0.590 |
Why?
| Surgery, Computer-Assisted | 2 | 2024 | 54 | 0.570 |
Why?
| Eosinophilia | 1 | 2017 | 36 | 0.550 |
Why?
| Indomethacin | 1 | 2016 | 38 | 0.540 |
Why?
| Pregnancy Complications | 1 | 2021 | 363 | 0.540 |
Why?
| Bile Duct Diseases | 1 | 2016 | 11 | 0.530 |
Why?
| Needles | 1 | 2016 | 24 | 0.530 |
Why?
| Biliary Tract Neoplasms | 1 | 2016 | 9 | 0.520 |
Why?
| Adenocarcinoma | 4 | 2024 | 401 | 0.510 |
Why?
| Pancreaticoduodenectomy | 1 | 2015 | 10 | 0.500 |
Why?
| Risk Assessment | 8 | 2021 | 1254 | 0.500 |
Why?
| Female | 30 | 2025 | 26560 | 0.490 |
Why?
| Liver Cirrhosis | 2 | 2024 | 225 | 0.490 |
Why?
| Jejunum | 1 | 2015 | 54 | 0.490 |
Why?
| Pancreatic Diseases | 3 | 2020 | 15 | 0.470 |
Why?
| Length of Stay | 6 | 2023 | 624 | 0.470 |
Why?
| Hemorrhage | 1 | 2016 | 194 | 0.470 |
Why?
| Male | 30 | 2025 | 25437 | 0.460 |
Why?
| Endoscopy | 4 | 2019 | 118 | 0.460 |
Why?
| Precancerous Conditions | 3 | 2020 | 83 | 0.450 |
Why?
| Treatment Outcome | 12 | 2025 | 5176 | 0.440 |
Why?
| Aged | 18 | 2025 | 9447 | 0.420 |
Why?
| Microscopy, Confocal | 5 | 2021 | 83 | 0.410 |
Why?
| Catheter Ablation | 3 | 2020 | 122 | 0.400 |
Why?
| Laparoscopy | 3 | 2024 | 170 | 0.380 |
Why?
| Middle Aged | 19 | 2023 | 12285 | 0.380 |
Why?
| Lipase | 2 | 2021 | 12 | 0.380 |
Why?
| Colorectal Neoplasms | 2 | 2025 | 253 | 0.370 |
Why?
| Smoking | 1 | 2015 | 506 | 0.370 |
Why?
| United States | 10 | 2024 | 4878 | 0.360 |
Why?
| Duodenoscopes | 2 | 2020 | 3 | 0.360 |
Why?
| Acute Disease | 4 | 2023 | 367 | 0.360 |
Why?
| Databases, Factual | 6 | 2022 | 660 | 0.350 |
Why?
| Adenomatous Polyps | 2 | 2020 | 8 | 0.330 |
Why?
| Pancreatic Ducts | 2 | 2019 | 12 | 0.330 |
Why?
| Colonic Polyps | 2 | 2020 | 36 | 0.320 |
Why?
| Gallbladder | 2 | 2019 | 25 | 0.320 |
Why?
| Multicenter Studies as Topic | 2 | 2023 | 89 | 0.320 |
Why?
| Adult | 14 | 2023 | 13346 | 0.320 |
Why?
| Cryotherapy | 2 | 2019 | 12 | 0.310 |
Why?
| Hospital Mortality | 3 | 2022 | 409 | 0.300 |
Why?
| Inpatients | 2 | 2022 | 193 | 0.290 |
Why?
| Time Factors | 3 | 2021 | 2891 | 0.290 |
Why?
| Aged, 80 and over | 8 | 2021 | 3136 | 0.280 |
Why?
| Pandemics | 3 | 2020 | 566 | 0.280 |
Why?
| Pneumonia, Viral | 2 | 2020 | 170 | 0.280 |
Why?
| Education, Medical, Graduate | 3 | 2024 | 211 | 0.280 |
Why?
| Cryosurgery | 2 | 2017 | 35 | 0.280 |
Why?
| Coronavirus Infections | 2 | 2020 | 179 | 0.280 |
Why?
| Esophagoscopy | 4 | 2021 | 27 | 0.280 |
Why?
| Patient Selection | 2 | 2019 | 254 | 0.270 |
Why?
| Ultrasonography, Interventional | 2 | 2024 | 137 | 0.260 |
Why?
| Abdominal Pain | 2 | 2023 | 84 | 0.260 |
Why?
| Proton Pump Inhibitors | 2 | 2023 | 85 | 0.250 |
Why?
| Fellowships and Scholarships | 2 | 2024 | 118 | 0.250 |
Why?
| New York | 4 | 2020 | 49 | 0.250 |
Why?
| Pancreatic Cyst | 2 | 2022 | 11 | 0.240 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2024 | 550 | 0.240 |
Why?
| Adenoma | 2 | 2024 | 111 | 0.240 |
Why?
| Registries | 3 | 2022 | 522 | 0.240 |
Why?
| Quality of Life | 3 | 2023 | 837 | 0.240 |
Why?
| Pancreatitis, Acute Necrotizing | 2 | 2021 | 6 | 0.230 |
Why?
| Esophageal and Gastric Varices | 1 | 2024 | 14 | 0.230 |
Why?
| Patient Readmission | 3 | 2022 | 222 | 0.230 |
Why?
| Computer Systems | 1 | 2004 | 21 | 0.230 |
Why?
| Gastroesophageal Reflux | 1 | 2024 | 50 | 0.230 |
Why?
| Crohn Disease | 2 | 2015 | 90 | 0.230 |
Why?
| Esters | 1 | 2023 | 18 | 0.230 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2023 | 12 | 0.230 |
Why?
| Guanidines | 1 | 2023 | 29 | 0.230 |
Why?
| Quality Indicators, Health Care | 1 | 2024 | 86 | 0.220 |
Why?
| Hepatic Encephalopathy | 1 | 2023 | 28 | 0.220 |
Why?
| Helicobacter pylori | 1 | 2024 | 66 | 0.220 |
Why?
| Helicobacter Infections | 1 | 2024 | 64 | 0.220 |
Why?
| Nitrogen | 3 | 2019 | 67 | 0.220 |
Why?
| Disease Progression | 2 | 2024 | 820 | 0.220 |
Why?
| Societies, Medical | 1 | 2024 | 177 | 0.220 |
Why?
| Esophageal Diseases | 1 | 2023 | 20 | 0.210 |
Why?
| Food | 1 | 2023 | 68 | 0.210 |
Why?
| Polyps | 2 | 2020 | 20 | 0.210 |
Why?
| Education, Medical, Undergraduate | 1 | 2004 | 83 | 0.210 |
Why?
| Severity of Illness Index | 3 | 2020 | 953 | 0.210 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 32 | 0.210 |
Why?
| Cystadenoma, Serous | 1 | 2022 | 5 | 0.210 |
Why?
| Gastric Mucosa | 3 | 2017 | 48 | 0.210 |
Why?
| Sutures | 1 | 2022 | 39 | 0.200 |
Why?
| Pancreatic Pseudocyst | 2 | 2018 | 7 | 0.200 |
Why?
| Suture Techniques | 1 | 2022 | 57 | 0.200 |
Why?
| Portasystemic Shunt, Surgical | 1 | 2021 | 5 | 0.200 |
Why?
| Life Tables | 1 | 2021 | 7 | 0.190 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2021 | 1 | 0.190 |
Why?
| Poliovirus Vaccines | 1 | 2021 | 2 | 0.190 |
Why?
| Measles Vaccine | 1 | 2021 | 4 | 0.190 |
Why?
| Students, Medical | 1 | 2004 | 159 | 0.190 |
Why?
| Internet | 1 | 2004 | 261 | 0.190 |
Why?
| Predictive Value of Tests | 2 | 2021 | 907 | 0.190 |
Why?
| Periodicals as Topic | 1 | 2022 | 57 | 0.190 |
Why?
| Young Adult | 3 | 2021 | 4029 | 0.190 |
Why?
| Image-Guided Biopsy | 1 | 2021 | 33 | 0.180 |
Why?
| Biopsy, Large-Core Needle | 1 | 2021 | 31 | 0.180 |
Why?
| Hepatitis E | 1 | 2020 | 5 | 0.180 |
Why?
| Duodenoscopy | 1 | 2020 | 2 | 0.180 |
Why?
| Hepatitis E virus | 1 | 2020 | 9 | 0.180 |
Why?
| Child | 3 | 2021 | 6844 | 0.180 |
Why?
| Gastrointestinal Diseases | 1 | 2022 | 128 | 0.180 |
Why?
| Cause of Death | 1 | 2021 | 147 | 0.180 |
Why?
| Prevalence | 2 | 2020 | 956 | 0.180 |
Why?
| Gastrointestinal Agents | 2 | 2024 | 35 | 0.180 |
Why?
| Severe Acute Respiratory Syndrome | 1 | 2020 | 17 | 0.180 |
Why?
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2022 | 46 | 0.180 |
Why?
| Recurrence | 2 | 2022 | 658 | 0.180 |
Why?
| Anemia | 1 | 2020 | 66 | 0.170 |
Why?
| Disinfection | 1 | 2019 | 12 | 0.170 |
Why?
| RNA, Viral | 1 | 2020 | 124 | 0.170 |
Why?
| Equipment Contamination | 1 | 2019 | 19 | 0.170 |
Why?
| Esophageal Sphincter, Lower | 1 | 2019 | 2 | 0.170 |
Why?
| Cholecystitis, Acute | 1 | 2019 | 9 | 0.170 |
Why?
| Odds Ratio | 2 | 2024 | 548 | 0.160 |
Why?
| Hepatitis C, Chronic | 1 | 2020 | 86 | 0.160 |
Why?
| Esophageal Achalasia | 1 | 2019 | 7 | 0.160 |
Why?
| Nursing Homes | 2 | 2010 | 113 | 0.160 |
Why?
| Clinical Competence | 2 | 2024 | 395 | 0.160 |
Why?
| Clinical Trials as Topic | 1 | 2022 | 466 | 0.160 |
Why?
| Plastics | 1 | 2018 | 10 | 0.160 |
Why?
| Ultrasonography | 1 | 2021 | 429 | 0.160 |
Why?
| Ambulatory Surgical Procedures | 1 | 2019 | 51 | 0.160 |
Why?
| Prospective Studies | 5 | 2023 | 2345 | 0.160 |
Why?
| Prosthesis Implantation | 1 | 2018 | 46 | 0.160 |
Why?
| Liver Transplantation | 1 | 2020 | 151 | 0.160 |
Why?
| Cohort Studies | 3 | 2021 | 1403 | 0.150 |
Why?
| Learning Curve | 1 | 2017 | 18 | 0.150 |
Why?
| Pancreatectomy | 1 | 2017 | 13 | 0.150 |
Why?
| Cholecystectomy, Laparoscopic | 1 | 2017 | 20 | 0.150 |
Why?
| Gastric Antral Vascular Ectasia | 1 | 2017 | 2 | 0.150 |
Why?
| Choledocholithiasis | 1 | 2017 | 13 | 0.150 |
Why?
| Stomach Neoplasms | 1 | 2020 | 187 | 0.140 |
Why?
| Administration, Rectal | 1 | 2016 | 10 | 0.140 |
Why?
| Lasers | 1 | 2017 | 107 | 0.130 |
Why?
| Multivariate Analysis | 2 | 2016 | 579 | 0.130 |
Why?
| Esophageal Stenosis | 1 | 2016 | 5 | 0.130 |
Why?
| Prosthesis Failure | 1 | 2017 | 108 | 0.130 |
Why?
| Device Removal | 1 | 2017 | 84 | 0.130 |
Why?
| Colonic Neoplasms | 1 | 2018 | 158 | 0.130 |
Why?
| Abscess | 1 | 2016 | 40 | 0.130 |
Why?
| Pain | 1 | 2019 | 374 | 0.130 |
Why?
| Costs and Cost Analysis | 1 | 2016 | 91 | 0.130 |
Why?
| Anesthesia | 1 | 2016 | 73 | 0.130 |
Why?
| Gastrointestinal Neoplasms | 1 | 2015 | 40 | 0.130 |
Why?
| Ticlopidine | 1 | 2015 | 55 | 0.120 |
Why?
| Chi-Square Distribution | 1 | 2016 | 275 | 0.120 |
Why?
| Anastomosis, Surgical | 1 | 2015 | 66 | 0.120 |
Why?
| Time-to-Treatment | 1 | 2016 | 70 | 0.120 |
Why?
| Remission Induction | 1 | 2015 | 205 | 0.120 |
Why?
| Patient Care Team | 1 | 2016 | 259 | 0.110 |
Why?
| Anti-Bacterial Agents | 1 | 2019 | 742 | 0.110 |
Why?
| Infant, Newborn | 1 | 2021 | 2729 | 0.110 |
Why?
| Immunologic Factors | 1 | 2015 | 112 | 0.110 |
Why?
| Models, Statistical | 1 | 2015 | 225 | 0.110 |
Why?
| Pregnancy | 1 | 2021 | 2468 | 0.110 |
Why?
| Logistic Models | 1 | 2016 | 895 | 0.110 |
Why?
| Infant | 1 | 2021 | 3572 | 0.110 |
Why?
| Child, Preschool | 1 | 2021 | 3875 | 0.100 |
Why?
| Case-Control Studies | 1 | 2016 | 1128 | 0.100 |
Why?
| Thrombosis | 1 | 2015 | 249 | 0.100 |
Why?
| Metals | 2 | 2024 | 35 | 0.090 |
Why?
| Adolescent | 4 | 2017 | 6414 | 0.090 |
Why?
| Residential Facilities | 1 | 2010 | 8 | 0.090 |
Why?
| Nurse Administrators | 1 | 2010 | 12 | 0.090 |
Why?
| Physician Executives | 1 | 2010 | 14 | 0.090 |
Why?
| Up-Regulation | 2 | 2021 | 446 | 0.080 |
Why?
| Activities of Daily Living | 1 | 2010 | 174 | 0.080 |
Why?
| Necrosis | 2 | 2021 | 175 | 0.080 |
Why?
| Biopsy | 2 | 2021 | 591 | 0.070 |
Why?
| Feasibility Studies | 2 | 2019 | 382 | 0.070 |
Why?
| Prognosis | 2 | 2021 | 1956 | 0.060 |
Why?
| Gastric Emptying | 1 | 2024 | 5 | 0.060 |
Why?
| Operative Time | 1 | 2025 | 71 | 0.060 |
Why?
| Obesity | 2 | 2023 | 1096 | 0.060 |
Why?
| Competency-Based Education | 1 | 2024 | 28 | 0.060 |
Why?
| Delphi Technique | 1 | 2024 | 54 | 0.060 |
Why?
| Computer Literacy | 1 | 2004 | 4 | 0.060 |
Why?
| India | 1 | 2004 | 52 | 0.060 |
Why?
| Consensus | 1 | 2024 | 155 | 0.050 |
Why?
| Cross-Sectional Studies | 2 | 2010 | 1573 | 0.050 |
Why?
| Random Allocation | 1 | 2004 | 285 | 0.050 |
Why?
| Artificial Intelligence | 1 | 2024 | 82 | 0.050 |
Why?
| Gastroscopy | 1 | 2022 | 19 | 0.050 |
Why?
| Data Collection | 1 | 2004 | 282 | 0.050 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2022 | 154 | 0.050 |
Why?
| Portal Pressure | 1 | 2021 | 4 | 0.050 |
Why?
| Double-Blind Method | 1 | 2023 | 679 | 0.050 |
Why?
| Portal Vein | 1 | 2021 | 25 | 0.050 |
Why?
| Software | 1 | 2004 | 274 | 0.050 |
Why?
| Early Detection of Cancer | 1 | 2023 | 163 | 0.050 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 168 | 0.050 |
Why?
| Follow-Up Studies | 2 | 2017 | 2175 | 0.050 |
Why?
| Clinical Enzyme Tests | 1 | 2020 | 3 | 0.050 |
Why?
| Renal Dialysis | 1 | 2022 | 170 | 0.050 |
Why?
| Decontamination | 1 | 2020 | 8 | 0.050 |
Why?
| Teaching Rounds | 1 | 2020 | 7 | 0.050 |
Why?
| Peptic Ulcer Hemorrhage | 1 | 2020 | 4 | 0.050 |
Why?
| Anastomosis, Roux-en-Y | 1 | 2020 | 4 | 0.050 |
Why?
| Personnel Staffing and Scheduling | 1 | 2020 | 20 | 0.050 |
Why?
| Overweight | 1 | 2023 | 213 | 0.040 |
Why?
| Genomics | 1 | 2022 | 284 | 0.040 |
Why?
| Uncertainty | 1 | 2020 | 43 | 0.040 |
Why?
| Congresses as Topic | 1 | 2020 | 45 | 0.040 |
Why?
| Ulcer | 1 | 2020 | 23 | 0.040 |
Why?
| Infection Control | 1 | 2020 | 47 | 0.040 |
Why?
| Blood Transfusion | 1 | 2021 | 125 | 0.040 |
Why?
| Erythrocyte Transfusion | 1 | 2020 | 50 | 0.040 |
Why?
| Data Interpretation, Statistical | 1 | 2021 | 159 | 0.040 |
Why?
| Education, Distance | 1 | 2020 | 41 | 0.040 |
Why?
| Body Mass Index | 1 | 2023 | 648 | 0.040 |
Why?
| Immunocompromised Host | 1 | 2020 | 119 | 0.040 |
Why?
| Linear Models | 2 | 2010 | 274 | 0.040 |
Why?
| Cholecystostomy | 1 | 2019 | 8 | 0.040 |
Why?
| Esophageal Motility Disorders | 1 | 2019 | 2 | 0.040 |
Why?
| Health Policy | 1 | 2020 | 151 | 0.040 |
Why?
| Intubation, Intratracheal | 1 | 2020 | 120 | 0.040 |
Why?
| Antiviral Agents | 1 | 2020 | 168 | 0.040 |
Why?
| Anxiety | 1 | 2020 | 273 | 0.040 |
Why?
| Dilatation, Pathologic | 1 | 2018 | 24 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2019 | 157 | 0.040 |
Why?
| Deglutition Disorders | 1 | 2019 | 75 | 0.040 |
Why?
| Tumor Burden | 1 | 2018 | 131 | 0.040 |
Why?
| Nitrous Oxide | 1 | 2017 | 12 | 0.040 |
Why?
| Prosthesis Design | 1 | 2018 | 240 | 0.040 |
Why?
| Retreatment | 1 | 2017 | 56 | 0.040 |
Why?
| Biomedical Research | 1 | 2020 | 241 | 0.040 |
Why?
| Tomography, Optical Coherence | 1 | 2018 | 104 | 0.040 |
Why?
| Cardia | 1 | 2016 | 10 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2020 | 1182 | 0.040 |
Why?
| Risk | 1 | 2018 | 314 | 0.030 |
Why?
| Treatment Failure | 1 | 2017 | 116 | 0.030 |
Why?
| Incidental Findings | 1 | 2017 | 39 | 0.030 |
Why?
| Esophagogastric Junction | 1 | 2017 | 33 | 0.030 |
Why?
| Biopsy, Needle | 1 | 2017 | 182 | 0.030 |
Why?
| Observer Variation | 1 | 2016 | 136 | 0.030 |
Why?
| Patient Safety | 1 | 2017 | 102 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2017 | 147 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 225 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2020 | 626 | 0.030 |
Why?
| Gastrostomy | 1 | 2016 | 55 | 0.030 |
Why?
| Algorithms | 1 | 2019 | 613 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 858 | 0.030 |
Why?
| Reoperation | 1 | 2017 | 453 | 0.030 |
Why?
| Telemedicine | 1 | 2020 | 465 | 0.030 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2015 | 174 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2017 | 972 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2018 | 1150 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2018 | 1525 | 0.020 |
Why?
| Physician-Nurse Relations | 1 | 2010 | 2 | 0.020 |
Why?
| Nursing Staff | 1 | 2010 | 15 | 0.020 |
Why?
| Institutionalization | 1 | 2010 | 11 | 0.020 |
Why?
| Fee-for-Service Plans | 1 | 2010 | 19 | 0.020 |
Why?
| Statistics as Topic | 1 | 2010 | 87 | 0.020 |
Why?
| Health Care Surveys | 1 | 2010 | 174 | 0.020 |
Why?
| Ambulatory Care | 1 | 2010 | 221 | 0.020 |
Why?
| Quality of Health Care | 1 | 2010 | 184 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 552 | 0.020 |
Why?
| Communication | 1 | 2010 | 246 | 0.020 |
Why?
|
|
Inamdar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|